Drug
Gsk3862995b
Gsk3862995b: highest development phase Phase 1, developed by GlaxoSmithKline. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- GlaxoSmithKline
Trials
| Drug | Phase | Indication |
|---|---|---|
| GSK3862995B NCT06154837 | Phase 1 | Pulmonary Disease, Chronic Obstructive |
Latest
No recent events.
Follow Gsk3862995b on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.